You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 1, January 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phytanic Acid in Patients With Refsum's Syndrome and Response to Dietary Treatment

Daniel Steinberg, MD; Charles E. Mize, MD; James H. Herndon, Jr., MD; Henry M. Fales, PhD; W. King Engel, MD; Frederic Q. Vroom, MD

Arch Intern Med. 1970;125(1):75-87.


Abstract

Metabolic studies in two patients with Refsum's syndrome provide further evidence that the phytanic acid stored has a strictly exogenous origin. On a highly restricted diet the phytanic acid levels in blood and in adipose tissue fell dramatically over a period of months. This was accompanied by a number of manifestations of clinical improvement, including increase in ulnar nerve conduction velocity, increase in strength of several muscle groups, return of some previously unobtainable reflexes, improvement in pain, light touch and position sense, and improvement in objective tests of coordination. There was no improvement in vision or hearing. The results support the hypothesis that accumulation of phytanic acid plays a pathogenetic role in Refsum's disease and justify further therapeutic trials.



Author Affiliations

La Jolla, Calif, and Bethesda, Md; Bethesda, Md

From the Division of Metabolic Disease, Department of Medicine, University of California at San Diego, La Jolla (Dr. Steinberg), and the Laboratory of Metabolism, National Heart Institute (Drs. Steinberg, Mize, Herndon, and Fales) and the Medical Neurology Branch, National Institute of Neurologic Diseases and Stroke (Drs. Engel and Vroom), Bethesda, Md. Dr. Mize is now with the Department of Pediatrics and Dr. Herndon is with the Department of Medicine, University of Texas Southwestern Medical School, Dallas. Dr. Vroom is now with the Division of Neurology, University of Florida School of Medicine, Gainesville.


Footnotes

Received for publication June 20, 1969; accepted July 23.

Reprint requests to Division of Metabolic Disease, Department of Medicine, University of California at San Diego, La Jolla, Calif 92037 (Dr. Steinberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Refsum's disease
Wills et al.
QJM 2001;94:403-406.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.